| |
Oral PCSK9 Inhibitor in Phase 3; vs Placebo, vs Nonstatins
|
| |
| |
Efficacy and Safety of Enlicitide, an oral PCSK9 Inhibitor, For Lowering LDL Cholesterol in Adults with or At Risk for ASCVD: The Phase 3 CORALREEF Lipids Trial..... https://www.natap.org/2025/HIV/111325_02.htm
ENLICITIDE DECANOATE, AN ORAL PCSK9 INHIBITOR, IN PARTICIPANTS WITH HETEROZVYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A DOUBLE-BLIND, PHASE 3, RANDOMIZED PLACEBO-CONTROLLED TRIAL ... . https://www.natap.org/2025/HIV/112025_01.htm
------------------------
|
|
| |
| |
|
|
|
